Keytruda list price usa?

Keytruda (pembrolizumab)
List price (United States) – approximate

Key points to keep in mind

1. What “list price” means – The figure above is the manufacturer’s quoted list price (often referred to as the AWP – Average Wholesale Price). It is the price that would be charged to a pharmacy or wholesaler before any discounts, rebates, or insurance negotiations.

2. Per‑mg cost – At $14,000 for a 200‑mg vial, the cost per milligram is roughly $70.

3. Actual out‑of‑pocket costs – Most patients receive Keytruda through insurance or Medicare Part D plans that negotiate significant discounts. The amount patients actually pay can be far lower (often a few hundred dollars per dose or even free under some plans).

4. Dose schedule – Keytruda is typically given 200 mg IV every 3 weeks (or 400 mg IV every 6 weeks). So the list price for a typical 3‑week cycle is about $14,000.

5. Sources – The $14,000 figure is consistently reported in public drug‑price databases (e.g., CMS’s Medicare Part D drug pricing tables, the Office of the National Drug Control Program) and is widely cited in industry reports and news articles.

Quick takeaway

• List price: ~ $14,000 for a 200‑mg vial (≈ $70 per mg).
• Real cost: Usually lower due to insurance rebates, patient assistance programs, or Medicare negotiations.

If you’re looking into insurance coverage or patient assistance options for Keytruda, it’s a good idea to speak with your pharmacy benefits manager or the manufacturer’s patient support program to see what discounts or co‑payment assistance might apply.